Nottingham leads £2.6m international clinical trial into new stroke treatment

CT scan of the human brain
18 Mar 2013 15:17:31.333
PA 84/13

Scientists in Nottingham are leading an international study to investigate the effectiveness of a new treatment on a devastating type of stroke.

The team at The University of Nottingham has been awarded £2.6 million by the National Institute for Health Research Health Technology Assessment (NIHR HTA) Programme to lead the clinical trial into the use of the drug tranexamic acid in people who have suffered an intracerebral haemorrhage, a type of stroke caused by bleeding in the brain.

Leading the trial, Dr Nikola Sprigg in the University’s Division of Stroke, said: “This is potentially very exciting — this drug could offer new hope for a condition for which there is currently no effective treatment.
Click here for full story

Story credits

More information is available from Dr Nikola Sprigg and the TICH-2 trials team on +44 (0)115 8231770, tich-2@nottingham.ac.uk

Emma Thorne Emma Thorne - Media Relations Manager

Email: emma.thorne@nottingham.ac.uk Phone: +44 (0)115 951 5793 Location: University Park

Additional resources

No additional resources for this article

Related articles

MBE for Nottingham stroke expert

Published Date
Wednesday 4th January 2012

TARDIS trial seeks new dimension in stroke treatment

Published Date
Monday 17th October 2011

Getting out of the house after stroke

Published Date
Monday 11th October 2010

How the EU could help more children survive cancer

Published Date
Thursday 23rd May 2013

Media Relations - External Relations

The University of Nottingham
YANG Fujia Building
Jubilee Campus
Wollaton Road
Nottingham, NG8 1BB

telephone: +44 (0) 115 951 5798
email: pressoffice@nottingham.ac.uk